Sandoz, the pioneer and global leader in biosimilars.

Sandoz is committed to increasing patient access to high-quality, life-enhancing biosimilars. It is the pioneer and global leader in biosimilars. In Canada, Sandoz markets six products: Omnitrope®, Erelzi®, Zientenzo®, Riximyo®, Hyrimoz® and Inclunox®.

With 20 years of extensive experience in biosimilar development, we have become the global market leader in biosimilars.